drugset / Trial / NCT01733043

Sedative Effects in Obstructive Sleep Apnea

NCT01733043

Phase 2/3 Withdrawn Duke University
RandomizedCrossoverQuadruple-blindTreatment

Summary

The objective of this study is to determine the effect of dexmedetomidine infusion on the Apnea / Hypopnea Index (AHI) of individuals with previously documented obstructive sleep apnea. We hypothesize that dexmedetomidine infusion may reduce the AHI in patients with obstructive sleep apnea (OSA).

Timeline

Start
2015-03
Primary completion
2015-05
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.6 ug/kg